Newsroom

Healthcare Pharmaceutical Biotech

Stay informed with the latest in Healthcare, Pharmaceutical and Biotech press releases through our newsroom. Explore breaking updates, industry trends, and insights shaping these vital sectors—all in one place. Whether it’s innovation, regulatory changes, or breakthroughs, our newsroom keeps you connected to the stories that matter most.

All News

A Digital Guardian: AI-Powered Insights Bring Patients and Clinicians Closer
Healthcare & PharmaceuticalEnvironmental, Social and Governance

A Digital Guardian: AI-Powered Insights Bring Patients and Clinicians Closer

April 2, 2026 8:35 AM

Key TakeawaysCombatting Home Modality Loss: To help address the 30% of patients who leave peritoneal dialysis (PD)- a home treatment option - within two years of starting treatment, DaVita developed and deployed a predictive AI model that supports clinical teams in identifying patients needs to sustain home dialysis.Closing the Visibility Gap: DaVita's connected cyclers and CWOW system provide care teams with consistent patient updates and data...

Read more
Dermata Receives Notice of Acceptance of Australian Patent Application for Topical Application of Dermal Fillers with its Bioneedle Delivery System
Healthcare & PharmaceuticalCompany Update

Dermata Receives Notice of Acceptance of Australian Patent Application for Topical Application of Dermal Fillers with its Bioneedle Delivery System

April 2, 2026 8:30 AM

Dermata Therapeutics, Inc. (Nasdaq:DRMA)(Nasdaq:DRMAW) ("Dermata" or the "Company"), a science-driven leader in dermatologic solutions, today announced the Australian Patent Office has accepted its patent application for its topical dermal filler program utilizing its BDS. The patent, entitled "Compositions for the treatment of conditions by dermal fillers," (Australian Patent Application No. 2020315876) continues to strengthen Dermata's global...

Read more
Side-by-Side Conference Hosts Close to 800 Participants in Malta to Advance Women's Health Care
Healthcare & PharmaceuticalConferences

Side-by-Side Conference Hosts Close to 800 Participants in Malta to Advance Women's Health Care

April 2, 2026 8:10 AM

Developed in collaboration with internationally recognized experts and grounded in peer-reviewed data, the program provided evidence-based updates on recent advances and innovations across key therapeutic areas, underscoring scientific integrity and evidence-based discussions. Beyond the science, the conference brought into focus how effective communication between healthcare professionals and patients can lead to improved diagnostic accuracy,...

Read more
Black Book Recognizes Innovaccer as a 2026 Leader in AI-Powered Revenue Cycle Autonomy and Population Health Data Activation
Healthcare & PharmaceuticalAwards

Black Book Recognizes Innovaccer as a 2026 Leader in AI-Powered Revenue Cycle Autonomy and Population Health Data Activation

April 2, 2026 7:00 AM

Black Book Research has recognized Innovaccer with top-ranked distinction in two 2026 healthcare technology evaluations: AI-Powered Revenue Cycle Autonomy and Population Health Data Integration, Activation & Analytics. Taken together, the findings point to a broader market transition now underway across healthcare operations: buyers are moving beyond reporting-centric tools and isolated automation toward platforms that unify data, orchestrate...

Read more
MedMira Reports Second Quarter Results FY2025
Healthcare & PharmaceuticalEarnings

MedMira Reports Second Quarter Results FY2025

April 1, 2026 10:00 PM

MedMira Inc. (MedMira) (TSXV:MIR), reported today on its financial results for the quarter ended January 31, 2026.Corporate updateIn Q2 FY2026, the Company signed a distribution agreement with McKesson, the world's second largest wholesalers in health care. This partnership allows MedMira to reach more customers and benefit from an excellent service and network provided by a leading supplier of medical and surgical products in North America....

Read more
VSee Health Reports 2025 Financial Results: Revenue Grows 40% Year-over-Year with a Strong Year End Balance Sheet
Healthcare & PharmaceuticalCompany Update

VSee Health Reports 2025 Financial Results: Revenue Grows 40% Year-over-Year with a Strong Year End Balance Sheet

April 1, 2026 4:00 PM

VSee Health, Inc. (Nasdaq:VSEE), a leader in AI-powered telehealth technology and high-acuity virtual care solutions, today reported its financial and operational results for the full year ended December 31, 2025. The Company delivered strong top-line growth and meaningful margin improvement while significantly narrowing its net loss.Key Financial Highlights (Year-over-Year Comparisons)Revenue increased 40% to $14,618,184 in 2025 from...

Read more
Ida Shlain Calls for Greater HIV Awareness and Community Care
Healthcare & PharmaceuticalCompany Update

Ida Shlain Calls for Greater HIV Awareness and Community Care

April 1, 2026 3:20 PM

Veteran California pharmacist Ida Shlain is speaking out to raise awareness about the ongoing need for HIV education, testing, and community support after more than three decades working with patients in Los Angeles.Shlain, who served as pharmacist-in-charge and owner of Capitol Drugs Pharmacy in West Hollywood, says her career placed her at the center of one of the most difficult public health moments in modern history: the HIV/AIDS crisis that...

Read more
Howard Kessler Salutes President Trump on Expanding Access to Innovative CBD Therapies for Seniors
Healthcare & PharmaceuticalCompany Update

Howard Kessler Salutes President Trump on Expanding Access to Innovative CBD Therapies for Seniors

April 1, 2026 3:15 PM

The Centers for Medicare & Medicaid Services (CMS) announced today a new Medicare pilot initiative, under the Trump administration, enabling eligible seniors to access federally compliant, hemp-derived CBD products free of charge through participating healthcare providers within Center for Medicare and Medicaid Innovation demonstration programs. Below is a statement from The Commonwealth Project Founder Howard Kessler on this historic...

Read more
TRNR Publishes Q4 & Year-End 2025 Shareholder Letter Discussing Record Results & Expectations for 2026 Given Company Transformation
Healthcare & PharmaceuticalCompany Update

TRNR Publishes Q4 & Year-End 2025 Shareholder Letter Discussing Record Results & Expectations for 2026 Given Company Transformation

April 1, 2026 3:10 PM

Interactive Strength Inc. (Nasdaq:TRNR) ("TRNR" or the "Company"), maker of innovative specialty fitness equipment under the Wattbike, CLMBR and FORME brands, today published a shareholder letter providing additional CEO commentary on 2025's record results.The full shareholder letter is available on the Company's website. Shareholders may register for updates at interactivestrength.com/updates or contact the Company at...

Read more
Cosmos Health Announces Successful EN 12791 Study Results for C-Scrub Wash 4%, Strengthening Expansion into Hospital and Surgical Markets
Healthcare & PharmaceuticalProduct Announcements

Cosmos Health Announces Successful EN 12791 Study Results for C-Scrub Wash 4%, Strengthening Expansion into Hospital and Surgical Markets

April 1, 2026 11:42 AM

Cosmos Health Inc. ("Cosmos Health" or the "Company") (NASDAQ:COSM), a diversified, vertically integrated global healthcare group, today announced that C-Scrub Wash 4%, manufactured by its wholly owned subsidiary Cana Laboratories S.A., has successfully completed testing under EN 12791:2016+A1:2017, the European standard for surgical hand disinfection.The independent study, conducted by Quality Assurance & Control Systems Ltd. (QACS), a...

Read more
Desert Oasis Healthcare Earns Gold Recognition from American Heart Association for Commitment to Employee Well-Being
Healthcare & PharmaceuticalAwards

Desert Oasis Healthcare Earns Gold Recognition from American Heart Association for Commitment to Employee Well-Being

April 1, 2026 10:00 AM

Desert Oasis Healthcare has been awarded Gold recognition from the American Heart Association as part of the 2026 Well-being Works Better™ Scorecard, underscoring the organization's ongoing commitment to supporting the health and well-being of its employees.The Well-being Works Better™ Scorecard is built on the American Heart Association's century-long legacy of advancing health and is designed to help organizations create thriving, supportive...

Read more
Phase II Clinical Trial of Monkeypox Treatment by NV-387 to Commence Soon, Announces NanoViricides
Healthcare & PharmaceuticalCompany Update

Phase II Clinical Trial of Monkeypox Treatment by NV-387 to Commence Soon, Announces NanoViricides

April 1, 2026 8:30 AM

NanoViricides, Inc. (NYSE American:NNVC) (the "Company") today announced that a Phase II Clinical Trial of Monkeypox Treatment by NV-387 is expected to begin soon in the Democratic Republic of Congo (DRC).Clinical Trial Site preparations are being performed by our CRO in India, Om Sai Clinical Research Pvt. Ltd., and associates in DRC. The CRO personnel are expected to visit the Site for final preparations and for staff training in the first...

Read more
Pharma Fusion and Santa Rosa Merger
Healthcare & PharmaceuticalMergers and Acquisitions

Pharma Fusion and Santa Rosa Merger

April 1, 2026 8:00 AM

Pharma Fusion announced today, it has entered into a Strategic Merger Agreement with Santa Rosa Pharmacy, uniting two specialty pharmacy leaders under a single, patient-centered platform.The combined integration creates a scaled, national specialty pharmacy with deep clinical expertise in bleeding disorders, immunoglobulin (Ig) therapies, and hereditary angioedema (HAE), designed to deliver high-touch care for patients living with complex and...

Read more
STEM CELL Recovery and Follow-Up: What Patients Need to Know After Treatment
Healthcare & PharmaceuticalCompany Update

STEM CELL Recovery and Follow-Up: What Patients Need to Know After Treatment

April 1, 2026 8:00 AM

Stem cell therapy has transformed the treatment landscape for several serious conditions, including blood disorders such as sickle cell disease. While the procedure itself is a critical milestone, the recovery and follow-up phase is equally important for ensuring long-term success. At Liv Hospital, a structured and patient-focused recovery plan helps individuals transition safely from treatment to daily life.Understanding STEM CELL Recovery and...

Read more
Bristol Myers Squibb Evolves and Expands Standing in the Gaap To Advance More Equitable Care in Multiple Myeloma As Program Marks Ten Years
Healthcare & PharmaceuticalEnvironmental, Social and Governance

Bristol Myers Squibb Evolves and Expands Standing in the Gaap To Advance More Equitable Care in Multiple Myeloma As Program Marks Ten Years

April 1, 2026 7:29 AM

Originally published by Bristol Myers SquibbBristol Myers Squibb (NYSE:BMY, "BMS"), a global leader in oncology, announced the evolution of Standing in the Gaap, a long-running program designed to help address persistent gaps in care for people living with multiple myeloma (MM) in medically underserved communities. Building on a decade of sustained commitment, BMS is reinforcing its focus on equitable access to multiple myeloma education,...

Read more
Annual Report 2025
Healthcare & PharmaceuticalEarnings

Annual Report 2025

April 1, 2026 7:13 AM

XVIVO Perfusion AB (STO:XVIVO)(LSE:0RKL)(FRA:3XV) - Today XVIVO Perfusion AB (publ) publish the Annual Report for 2025. The Annual Report is attached to this press release in pdf format and in ESEF format and is also available on https://investor.xvivogroup.com/financials#reports.April 1, 2026Molndal, SwedenXVIVO Perfusion AB (publ)For further information, please contact:Christoffer Rosenblad, CEO, +46 73 519 21 59, e-mail:...

Read more
Sapyen Bundles At-Home Fertility Hormone Testing for Couples to Cut Delays in Healthcare
Healthcare & PharmaceuticalProduct Announcements

Sapyen Bundles At-Home Fertility Hormone Testing for Couples to Cut Delays in Healthcare

April 1, 2026 6:50 AM

Fertility testing in the UK is starting to look very different. Instead of multiple appointments, referrals, and weeks of waiting, a new model is emerging where both partners can test at home, at the same time, and walk into their first clinic appointment with answers already in hand. Sapyen, a fertility diagnostics company used by leading IVF clinics such as Avenues, has launched a combined at-home testing suite that brings together male...

Read more
WEED Inc (OTCQB:BUDZ) Looks to Advance a High-Value AI Data Center Opportunity for The Four Winds of Lake Erie, LLC. On Our Prime Lake Erie Waterfront Property
Healthcare & PharmaceuticalCompany Update

WEED Inc (OTCQB:BUDZ) Looks to Advance a High-Value AI Data Center Opportunity for The Four Winds of Lake Erie, LLC. On Our Prime Lake Erie Waterfront Property

April 1, 2026 6:00 AM

WEED Inc. (OTCQB:BUDZ) today announced a major step forward in unlocking significant shareholder value through the planned redevelopment of its wholly owned subsidiary, The Four Winds of Lake Erie, LLC. fka Sugar Hill Golf Course property into a next-generation data center campus.In a key development, the Town of Portland NY, Board has formally expressed its support for the concept of a data center project at the site-signaling strong municipal...

Read more
Evotec SE to Announce Fourth Quarter and Full-Year 2025 Results on April 8, 2026
Healthcare & PharmaceuticalCompany Update

Evotec SE to Announce Fourth Quarter and Full-Year 2025 Results on April 8, 2026

April 1, 2026 5:35 AM

Evotec SE (NASDAQ:EVO)(Frankfurt Prime Standard:EVT) will hold a webcast and conference call to announce its financial results for the fourth quarter and full-year 2025 and provide a business update on Wednesday, April 8, 2026. The conference call will be held in English.Webcast detailsDate: Wednesday, April 8, 2026Time: 2.00 pm CEST (12.00 pm GMT, 8.00 am EDT)To join the audio webcast and to access the presentation slides, please register via...

Read more
AlzeCure Pharma to Present at Redeye Alzheimer's Theme Event on April 9
Healthcare & PharmaceuticalCompany Update

AlzeCure Pharma to Present at Redeye Alzheimer's Theme Event on April 9

April 1, 2026 4:15 AM

AlzeCure Pharma AB (publ) (STO:ALZCUR)(FRA:AC6), a biotech company that develops candidate drugs for diseases affecting the nervous system, focusing on Alzheimer's disease and pain, today announced that it will participate in the Redeye Alzheimer's Theme Event on April 9, where CEO Martin Jönsson and CSO Johan Sandin will present the company and its project portfolio within Alzheimer's. The presentation will be followed by a Q&A session...

Read more

Join the thousands of ACCESS Newswire customers today who are getting millions of views on their news.


Check out our flexible subscription and pay as you go pricing

and packages.

Use Code NEWS10 for 10% off  of your first purchase.


Latest Blog Posts

Visit our blogs for press release tips, media engagement

Strategies, and Product Comparisons.

Executive delivering prepared remarks from an earnings call script
By Jennifer Hammers July 9, 2026
How to write earnings call prepared remarks that land — structure, length, the safe-harbor open, non-GAAP language, and building remarks around your strategy.
IR
By Brian Balbirnie July 8, 2026
A practical earnings call preparation checklist for IR teams — the two-week runway, consensus, logistics, Q&A prep, and Reg FD-clean disclosure timing.
ACCESS Newswire guide on AI investor relations — how AI assistants read company earnings disclosures
By Jennifer Hammers July 6, 2026
AI assistants read your earnings within minutes. Learn how IR teams make disclosures AI-readable — and how the LLM Citation Score measures your visibility.
What does Meltwater cost in 2026, and what are the alternatives? Meltwater resells press release dis
By Jennifer Hammers June 22, 2026
What does Meltwater cost in 2026, and what are the alternatives? See how ACCESS Newswire compares on distribution, data, and price.
A logo for accesswire next to a logo for rack
By Jennifer Hammers June 21, 2026
Compare Muck Rack vs ACCESS Newswire on pricing, features, and alternatives. See how ACCESS Newswire adds distribution, pitching, and analytics.
A blue and white logo with a check mark next to it
By Jennifer Hammers June 19, 2026
Compare Business Wire vs ACCESS Newswire on pricing and capabilities — and how ACCESS delivers comparable reach at a fraction of the cost.
Show More




Discover the news
by Industry:


Need help with your PR Strategy?
Learn more about our
professional PR Services today:

.MEDIA PRO 
Want to get noticed
by the Media but don’t
know how? 

.TOTAL PRO

Need full support to 

Optimize your PR

Efforts?